Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-hydroxyapatite Toothpaste for Dentin Hypersensitivity
NCT06493500Phase 1Not yet recruiting
- Sponsor
- Cairo University
- Start
- Jul 2024
- Primary completion
- Feb 2025
- Modality
- Hydrogel Systems, Nanoparticles, Device-based Delivery
01
Overview
Phase 1, randomised trial of nanohydroxyapatite in dentin hypersensitivity (DH) (3 arms), sponsored by Cairo University. Primary endpoint: Pain intensity due to Dentin Hypersensitivity by Visual Analogue Scale at 6 months. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
nanohydroxyapatite
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT06493500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06493500.